Reinventing Healthcare through AI

Do not miss this webinar on Thursday, April 2nd with Ken Xiong, Senior Manager of Innovation Collaboration, Merck Innovation Hub China. We will discuss how to reinvent healthcare through AI.

我们有幸邀请到默克中国创新中心的创新合作高级经理熊耿，在4月2日周四下午，一起探讨如何通过人工智能重塑医疗健康行业。如果你有兴趣，就不要错过下午1点的网络研讨会!

Register here:

https://startupgrind.zoom.us/webinar/register/WN_pGbDoofzQ6WdiEVx2t1nKg

About the Speaker

关于演讲者

Ken Xiong, Senior Manager of Innovation Collaboration, Merck Innovation Hub China

Ken Xiong is responsible for scouting the best science and technology start-ups to collaborate with and invest in, and foresight of innovation field for Merck China Innovation Hub. Before this, he was working in the VC arm of Fosun Pharma to invest in global innovation-driven start-ups in healthcare sector. Meanwhile, he was also experienced in technology transfer and incubation. He is a biologist by training and holds a PhD degree of Oncology from Sun Yat-sen University. He also attended a joint PhD program of Harvard Medical School, and got trained at Brigham and Women’s Hospital in Boston.

熊耿，默克中国创新中心创新合作高级经理。

熊耿负责挑选最佳科技初创企业，与默克中国创新中心合作，在创新领域进行投资。在此之前，他曾在复星医药的风投部门工作，投资于全球创新驱动的医疗保健初创企业。同时，他在技术转让和孵化方面也很有经验。他是一名资深的生物学家，并拥有中山大学肿瘤学博士学位，他参加了哈佛医学院的联合博士学位课程，并曾在波士顿的布莱根妇女医院培训。

About Merck Accelerator

关于默克加速器

The objective of the Accelerator program is to identify promising startups, connect them to relevant business sectors and build pilot projects to foster to innovation projects of Merck and its three business sectors for co-development and a sustainable business partnership. With focus on startups in the seed to series A financing round in the fields of healthcare, performance materials, life sciences, AI enabled health solutions, organoid, bioelectronics, liquid biopsy, neuromorphic system and clean meat.

The application for the third intake of China Accelerator program is open from March 3, 2020 until March 31, 2020. Apply now at 'Read more' at the bottom left of this article.

默克加速器项目作为链接默克与初创企业的纽带，致力于发掘有潜力的初创企业，为他们的业务发展提供支持并建立合作，共同探讨和推动为世界创造价值的创新商业机会。为期三个月的默克中国加速器一年将分为两期进行，重点关注医药健康、生命科学、高性能材料、人工智能健康解决方案、类器官、生物电子、液体活检技术、神经形态系统和清洁肉等领域，处于种子期至A轮融资的初创公司。默克中国加速器第三期已正式开启招募，第一批招募时间为2020年3月3日-3月31日。点击“阅读原文”立即报名。

About Merck Innovation Hub China

关于默克创新中心

As an important part of Merck’s global innovation network, the China Innovation Hub scouts, incubates and invests in innovative opportunities in healthcare, life science, performance materials and related fields between and beyond the existing businesses. Embedded into China’s innovation ecosystem, Merck Innovation Hub China is committed to partnering with start-ups, academic institutions, industry players and local governments, combining unique technology and expertise from Merck Group and collaborators with the goal to develop novel technology and bring new solutions to the market for China and global. The China Innovation Hub also provides support of ideation, incubation and trainings to local talents, partners and Merck employees to build win-win collaboration. For more information, please visit http://innovateinchina.merckgroup.com.

默克中国创新中心是默克全球创新网络的一个重要部分，致力于搜寻、孵化和投资医药健康、生命科学、高性能材料以及现有业务领域之间和之外的创新机会。默克中国创新中心植根中国创新生态，积极与初创企业、学术机构、业内伙伴和当地政府建立合作伙伴关系，整合默克集团与合作伙伴在各自相关领域的独特技术和专业技能，开发创新技术，为中国市场和全球业务带来新的解决方案，同时为本地创新人才、合作伙伴和默克员工提供创意激发培养和创新孵化支持，实现合作共赢。关于默克中国创新中心的更多信息，请访问http://innovateinchina.merckgroup.com。